52 results
8-K
EX-99.2
FENC
Fennec Pharmaceuticals Inc
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
with the SEC, may also be obtained from Cantor Fitzgerald & Co., 499 Park Avenue, 6th Floor, New York, NY 10022, Attn: Capital Markets Department
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
4 May 20
Fennec Announces Proposed Public Offering of Common Shares
12:00am
from Cantor Fitzgerald & Co., 499 Park Avenue, 6th Floor, New York, NY 10022, Attn: Capital Markets Department, or by email at prospectus@cantor.com
CORRESP
FENC
Fennec Pharmaceuticals Inc
12 Jan 11
Correspondence with SEC
12:00am
at the Cross Cancer Institute in Edmonton, Alberta and Associate Professor in the Faculty of Medicine at the University of Alberta, Chief of the Department … of Radiation Oncology at the London Regional Cancer Centre and Chairman of the Department of Oncology at Victoria Hospital Corporation. Dr. Porter
6-K
EX-99.2
FENC
Fennec Pharmaceuticals Inc
15 Feb 07
Adherex Announces Filing of Final Prospectus
12:00am
supported by two grant awards, a National Institutes of Health fellowship and a Howard Hughes Medical Institute fellowship in the department of biochemistry … , Alberta and Associate Professor in the Faculty of Medicine at the University of Alberta, Chief of the Department of Radiation Oncology at the London
6-K
EX-99.2
FENC
Fennec Pharmaceuticals Inc
22 Jan 07
Adherex Announces Equity Offering Up to US$25 Million
12:00am
fellowship in the department of biochemistry at UMDNJ Robert Wood Johnson Medical School.
Peter Morand, PhD.Dr. Morand has been a director of Adherex … at the Cross Cancer Institute in Edmonton, Alberta and Associate Professor in the Faculty of Medicine at the University of Alberta, Chief of the Department
20-F
krecasdr7shnahpbirr
31 Mar 05
Annual report (foreign)
12:00am
6-K
EX-99.3
yq3egs15
31 Mar 06
Current report (foreign)
12:00am
8-K
EX-10.1
5mu frjr1lhnps
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
20FR12B/A
idly3d6dws
5 Nov 04
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
aoeiveussm nko4fp2
17 Sep 04
Initial registration of securities (foreign private issuers)
12:00am
20FR12B/A
jdg5kqm
8 Oct 04
Initial registration of securities (foreign private issuers) (amended)
12:00am
8-K
EX-4.45
yyrpbd8n qlh4hykd
22 Feb 07
Adherex Completes US$25 Million Public Financing
12:00am
DEF 14A
1fyyuezkrenwgevnl9
3 Apr 07
Definitive proxy
12:00am